Summit Therapeutics Share Discussion Threads

[anusol] 23/9/2016 14:58

Are BMS still playing around in the background or did they wander off years ago?

[anusol] 23/9/2016 14:56

Minimum I'd accept would be £4 as that equates back to the 20p peak we saw about 3 years ago - but then a premium on that would be a welcome bonus

[waterloo01] 23/9/2016 14:03

Interesting times. Nothing damp with this Squib. Wainwright note rather well timed, followed by US traders buying in and the SRPT news (including today when they raised $300m at a premium and were 4/5 times over subscribed.

What next? Placing? RDZ news? Take over?

[sorrento06] 23/9/2016 13:43

I would be happy with £5. My average is 95p

[gwr7] 23/9/2016 13:24

At long last the ducks are lined up.

[handlebar123] 23/9/2016 13:06

Excellent prospects and way under-priced at current levels. I'm in ;-)

[chrisatrdg] 23/9/2016 12:20

Summit tweet:
Summit Therapeutics ‏@Summitplc Sep 20

We've updated with a map of our current clinical trial sites in the UK in PhaseOut DMD #Duchenne

[solomon] 23/9/2016 12:18

luminoso, I doubt that he knows any more than we do, now that he is not associated with the company.

[luminoso] 23/9/2016 12:06

Just a thought. Mellon's tweet is not the tweet of a man looking to get cheap placement shares. Good sign, IMO.

[someuwin] 23/9/2016 12:05

The big boys would be crazy not to buy out SUMM at these bombed out levels.

They have lots of cash but need new drugs.

SUMM has two new drugs but needs cash.

[chrisatrdg] 23/9/2016 11:44

Jim Mellon has tweeted me back 'liking my tweet'.

[solomon] 23/9/2016 11:28

It would be cheap for Sarepta to buy us out with the dolar being what it is. But don't give us Sarepta shares !!!!

[cautiousmoney] 23/9/2016 11:17

I have been in here that long CGT wont count :-)

[freedosh] 23/9/2016 11:17

No. 10 with a long, long way to go, IMO
I would not disagree with some of the long term values suggested above
I could even see Sarepta making an opportunistic offer as insurance
GLA

[luminoso] 23/9/2016 11:13

Good to let him know, I guess !

[chrisatrdg] 23/9/2016 11:09

I have re-tweeted back to Jim Mellon as follows:

I would say current shareholders incl. myself would be looking for much more than 3 pounds & C-Diff deal yet to come .

Edit: However I would be 166.75% up & plus £86k subject to CGT if it was £3 - I wonder if JM would accept that?

[luminoso] 23/9/2016 11:01

Not sure what freemoney is disagreeing with there re mellon's comment. IF there was an offer pre Phase 2 results, I guess £3 plus might be enough to tempt the main shareholders to cut and run. Yes, it will be worth so much more after P2, if all goes well, and I personally hope Summit runs its course but the reality is that we, the smaller shareholders, will have little say IF there was a substantial offer.

[chrisatrdg] 23/9/2016 10:51

Roll on 12.00.

[chrisatrdg] 23/9/2016 10:50

Per Free-Money this morning from the other board

RE: jimmy mellon

'No chance MellonMan.

He knows very well that DMD success with a drug attributable to 100% of the population is worth well over £30 a share and maybe pushing well over £100 with no further dilution on the current company stock.

We will be well over £3 a share just on the C.Diff deal.

In the words of another great investor...it's still a 'screaming buy' at these prices. GLA'

[solomon] 23/9/2016 10:43

Lovely sound to that quote from Jim. It is just an opinion though.

[someuwin] 23/9/2016 10:21

jim mellon ‏@jimmhk · 1 minute ago

"Summit plc is soaring ...must be a candidate for a take out post Sarepta DMD news.if so look for 3 pounds plus"

[hugus maximus] 23/9/2016 09:44

A little ray of sunshine after all that gloom!

[someuwin] 23/9/2016 09:39

Re-rating continues.